Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: | Telfast (General sale) |
Active Ingredient: | Fexofenadine hydrochloride 120mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
Manufacturers: | Sanofi Winthrop Industrie, Tours, France Sanofi Vietnam Shareholding Company, Ho Chi Minh City, Vietnam |
Product: | Telfast (Pharmacy only) |
Active Ingredient: | Fexofenadine hydrochloride 120mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
Manufacturers: | Sanofi Winthrop Industrie, Tours, France Sanofi Vietnam Shareholding Company, Ho Chi Minh City, Vietnam |
Product: | Telfast (General sale) |
Active Ingredient: | Fexofenadine hydrochloride 180mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
Manufacturers: | Sanofi Winthrop Industrie, Tours, France Sanofi Vietnam Shareholding Company, Ho Chi Minh City, Vietnam |
Product: | Telfast (Pharmacy only) |
Active Ingredient: | Fexofenadine hydrochloride 180mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
Manufacturers: | Sanofi Winthrop Industrie, Tours, France Sanofi Vietnam Shareholding Company, Ho Chi Minh City, Vietnam |
Dated this 7th day of June 2024.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).